Breaking News Instant updates and real-time market news.

CLLS

Cellectis

$23.00

-0.24 (-1.03%)

17:03
10/04/16
10/04
17:03
10/04/16
17:03

Cellectis licenses patent for gene inactivation system

Cellectis announced the issuance of U.S. patent 9,458,439, which claims gene inactivation by use of chimeric restriction endonucleases. This patent granted by the USPTO to the Institut Pasteur and Boston Children's Hospital naming Andre Choulika and Richard C. Mulligan as co-inventors, is exclusively licensed to Cellectis. This issued U.S. patent 9,458,439 claims the method of introducing chromosomal modifications at a locus by induction of double-stranded DNA cleavage using a chimeric restriction endonuclease and non-homologous end joining recombination.

  • 06

    Nov

CLLS Cellectis
$23.00

-0.24 (-1.03%)

12/07/15
OPCO
12/07/15
NO CHANGE
Target $65
OPCO
Outperform
Cellectis call confusion presents buying opportunity, says Oppenheimer
Oppenheimer analyst Christopher Marai attributes the weakness in shares of Cellectis (CLLS) to investor confusion after the company did not discuss UCART19 data on its call this morning. However, Marai said the company does not own the UCART19 patient data and further disclosure will come from its partners and that the stated purpose of this call was always to recap the terms of the company's updated pact with Servier and Pfizer (PFE). The analyst, who recommends buying the stock on the weakness, keeps an Outperform rating and $65 price target on Cellectis.
03/01/16
RHCO
03/01/16
INITIATION
Target $35
RHCO
Buy
Cellectis initiated with a Buy at SunTrust
Target $35.
04/05/16
LTCO
04/05/16
INITIATION
Target $45
LTCO
Buy
Cellectis initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Wangzhi Li started Cellectis with a Buy rating and $45 price target.
08/31/16
PIPR
08/31/16
NO CHANGE
PIPR
Piper's Schimmer unsure of impact from Novartis CAR-T shakeup
Piper Jaffray analyst Joshua Schimmer said he's struggling with the implications of the news that Novartis (NVS) is reportedly eliminating its Cell and Gene Therapy unit as a stand-alone entity, which is primarily focused on development of CAR-T and adoptive immunotherapies. On the one hand, removing a leading competitor is a positive for the rest of the field, Schimmer tells investors in a research note. On the other hand, the move by Novartis could signal "significant challenges" in the field, the analyst adds. Schimmer continues to prefer companies "with unique and differentiated approaches," namely Bellicum Pharmaceuticals (BLCM), Cellectis (CLLS), Lion Biotechnologies (LBIO), Amgen (AMGN), Celgene (CELG) and bluebird bio (BLUE). Juno Therapeutics (JUNO) and Kite Pharma (KITE) are down 6% and 5%, respectively, in midday trading.

TODAY'S FREE FLY STORIES

BHGE

Baker Hughes

$37.50

0.11 (0.29%)

08:04
09/21/17
09/21
08:04
09/21/17
08:04
Recommendations
Baker Hughes analyst commentary  »

Baker Hughes 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 20

    Oct

SCG

Scana

$57.80

-0.41 (-0.70%)

08:04
09/21/17
09/21
08:04
09/21/17
08:04
Hot Stocks
Scana receives subpoena for documents relating to nuclear project »

Scana announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TANH

Tantech Holdings

$4.07

0.08 (2.01%)

08:03
09/21/17
09/21
08:03
09/21/17
08:03
Hot Stocks
Tantech Holdings awarded $20M in electric van and bus sales orders »

Tantech Holdings'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VR

Validus

$46.93

1.2 (2.62%)

08:03
09/21/17
09/21
08:03
09/21/17
08:03
Recommendations
Validus analyst commentary  »

Validus net exposure to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOLD

Audentes Therapeutics

$26.57

1.04 (4.07%)

08:02
09/21/17
09/21
08:02
09/21/17
08:02
Hot Stocks
Audentes Therapeutics doses first patient in ASPIRO trial »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELGX

Endologix

$4.29

-0.15 (-3.38%)

08:01
09/21/17
09/21
08:01
09/21/17
08:01
Hot Stocks
Endologix announces CE Mark approval for Nellix system »

Endologix announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$156.07

-2.66 (-1.68%)

08:00
09/21/17
09/21
08:00
09/21/17
08:00
Options
Apple call buyer realizes 32% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

08:00
09/21/17
09/21
08:00
09/21/17
08:00
General news
Treasury Market Outlook: bonds remain mostly weaker »

Treasury Market Outlook:…

NVDA

Nvidia

, TSLA

Tesla

07:58
09/21/17
09/21
07:58
09/21/17
07:58
Technical Analysis
Technical View: AMD trades up on report it is working with Tesla on AI chip »

In the pre-market the AMD…

NVDA

Nvidia

TSLA

Tesla

AMD

AMD

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

JAKK

JAKKS Pacific

$3.15

0.325 (11.50%)

07:56
09/21/17
09/21
07:56
09/21/17
07:56
Downgrade
JAKKS Pacific rating change  »

JAKKS Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$114.94

-2.98 (-2.53%)

07:56
09/21/17
09/21
07:56
09/21/17
07:56
Conference/Events
Royal Caribbean management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RMBS

Rambus

$13.35

-0.23 (-1.69%)

07:55
09/21/17
09/21
07:55
09/21/17
07:55
Conference/Events
Rambus to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Oct

MO

Altria Group

$61.22

-1.01 (-1.62%)

07:54
09/21/17
09/21
07:54
09/21/17
07:54
Recommendations
Altria Group analyst commentary  »

Altria cigarette price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$136.77

0.03 (0.02%)

07:50
09/21/17
09/21
07:50
09/21/17
07:50
Conference/Events
Moody's management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

LII

Lennox

$170.37

4.54 (2.74%)

07:49
09/21/17
09/21
07:49
09/21/17
07:49
Conference/Events
Lennox management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 26

    Sep

APRN

Blue Apron

$5.22

-0.29 (-5.26%)

07:49
09/21/17
09/21
07:49
09/21/17
07:49
Technical Analysis
Technical View: Blue Apron trades highe as Plated acquired by Albertsons »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIVI

II-VI

07:48
09/21/17
09/21
07:48
09/21/17
07:48
Conference/Events
II-VI management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 28

    Sep

  • 13

    Nov

HSC

Harsco

$19.70

-0.2 (-1.01%)

07:47
09/21/17
09/21
07:47
09/21/17
07:47
Conference/Events
Harsco management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

TXN

Texas Instruments

$85.83

-0.98 (-1.13%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$438.17

6.79 (1.57%)

, AMGN

Amgen

$188.17

1.85 (0.99%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Regeneron, Amgen, AstraZeneca, AbbVie analyst commentary  »

Regeneron price target…

REGN

Regeneron

$438.17

6.79 (1.57%)

AMGN

Amgen

$188.17

1.85 (0.99%)

AZN

AstraZeneca

$32.93

0.26 (0.80%)

ABBV

AbbVie

$87.41

1.04 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

ALNY

Alnylam

$113.84

38.8 (51.71%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Alnylam analyst commentary  »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHF

Brighthouse Financial

$57.49

0.56 (0.98%)

07:43
09/21/17
09/21
07:43
09/21/17
07:43
Initiation
Brighthouse Financial initiated  »

Brighthouse Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$26.29

-1.42 (-5.12%)

07:42
09/21/17
09/21
07:42
09/21/17
07:42
Technical Analysis
Technical View: JinkoSolar slips in early trading, analyst action »

Shares were last down 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGG

Graco

$122.63

0.77 (0.63%)

07:40
09/21/17
09/21
07:40
09/21/17
07:40
Conference/Events
Graco management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DATA

Tableau

$75.25

-0.32 (-0.42%)

07:35
09/21/17
09/21
07:35
09/21/17
07:35
Recommendations
Tableau analyst commentary  »

Tableau price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.